BeOne Medicines valuation

ONC · NASDAQ · USD

Compare BeOne Medicines
$413.26Change from previous close: +0.48%Absolute change: +$1.97

Close · November 17, 2026

Valuation

The P/E ratio is 52.7. The average price target of 27 analysts is $469.23.

Data as of November 17, 2026

BeOne Medicines compared with similar companies

BeOne Medicines's P/E (trailing 12 months): 52.7, +35% against the median of a group of 6 similar companies (39.2).

BeOne Medicines's metrics compared with similar companies
MetricBeOne MedicinesMedian25th–75th percentileBand
P/E (trailing 12 months)52.739.224.0 – 50.9High
Forward P/E38.415.213.7 – 33.5High
EV/EBITDA32.620.815.8 – 24.6High
Price/book8.067.124.39 – 14.1Middle
Price/sales7.119.446.15 – 17.1Middle
Gross margin89.4%59.8%23.4% – 80.8%High
Operating margin17.8%17.8%-68.1% – 31.2%Middle
Net margin13.9%6.7%-19.9% – 27.1%Middle
ROE18.4%-0.2%-28.0% – 14.2%High
Debt/equity0.350.350.02 – 0.73Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$46.98B
Enterprise value
$43.26B
PEG
0.73
EV/revenue
6.55

Profitability and growth

ROA
8.4%
ROIC
62.6%
Revenue growth (year over year)
33.8%
Earnings growth (year over year)
212.5%

Financial health

Total cash
$5.78B
Total debt
$2.06B
Current ratio
3.55
Quick ratio
3.10
Piotroski F-Score
7.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$469.23
Median price target
$468.62
High price target
$561.30
Low price target
$400.00
Analysts with a price target
27
Consensus
Strong buy
Forward EPS
$10.72
EPS estimate, current year
$9.87

Shares and trading

Beta
0.63
Average volume
400.19K
Shares outstanding
105.38M
Float
81.36M
Institutional ownership
34.6%
Insider ownership
17.3%
Short interest (% of float)
2.0%
Short ratio (days)
4.32